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EXTENDED REPORT
Corneal graft rejection occurs despite Fas ligand expression
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Background/aims: Constitutive expression of Fas ligand (CD95L) protects the eye against cell mediated
immune responses by inducing apoptosis in infiltrating Fas bearing T cells. This study was designed to
examine Fas ligand expression on acutely rejecting rat corneal grafts and to investigate the kinetics of
induction of apoptosis in infiltrating leucocytes.
Methods: Orthotopic penetrating corneal transplantation was performed between genetically disparate
inbred rats. Fas ligand expression and the phenotype of infiltrating leucocytes were examined by
immunohistochemistry. Apoptotic nuclei were visualised in sections of normal rat cornea, rejecting
allografts, and time matched isografts by terminal deoxynucleotidyl transferase mediated dUTP biotin nick
end labelling (TUNEL) and quantified by video image analysis. Staining with Hoechst dye 33258 was used
to confirm the presence of apoptotic nuclei.
Results: Fas ligand was expressed on corneal endothelial and epithelial cells during acute corneal graft
rejection. At all time points examined, including as early as the fifth postoperative day, the cells infiltrating
both corneal isografts and allografts were TUNEL positive. By the 15th postoperative day, over 90% of all
nuclei, many of which were T cells, were apoptotic.
Conclusion: Expression of Fas ligand is not downregulated on the cornea during allograft rejection and
infiltrating leucocytes in both isografts and allografts die rapidly in situ. Despite the death of the cells
believed to be responsible for rejection, isografts survive indefinitely whereas allografts are irreparably
damaged.
T
he anterior segment of the eye is considered an
immunologically privileged site in which allografts and
xenografts exhibit prolonged survival.1 2 The mechanisms
by which ocular privilege may be maintained include
immunological ignorance, anterior chamber associated
immune deviation (ACAID), and constitutive expression of
Fas ligand (CD95L) on ocular tissue.1–8 Immunological
ignorance represents a failure of the afferent arm of the
immune response to be triggered by foreign antigen, or the
failure of effector cells to gain access to target tissue.2 ACAID,
which manifests as active suppression of the delayed type
hypersensitivity response to antigen introduced into the
anterior chamber, is mediated by immunosuppressive con-
stituents of normal aqueous humour coupled with products
of immunomodulatory effector cells generated through
aberrant antigen processing pathways.3 4 Constitutive expres-
sion of Fas ligand on ocular tissue induces apoptotic cell
death in infiltrating, Fas bearing T lymphocytes in a murine
model of ocular herpes simplex virus infection.5 Furthermore,
the incidence of corneal graft rejection increases markedly
when graft donors are Fas ligand negative (gld) mice.6–8
Close evaluation of the outcome of transplantation of
tissues at the anterior surface of the eye reveals that many
grafts do fail from immunological rejection.9 10 Kaplan-Meier
survival of penetrating corneal allografts in large patient
cohorts is approximately 60% at 10 years11 and the major
cause of graft failure is irreversible rejection.11 12 Similarly,
immunological rejection appears to limit the success of limbal
stem cell allotransplantation performed for bilateral blinding
ocular surface disease both in humans13 and experimental
animals14 in the absence of adequate immunosuppression.
Experimental corneal xenografts fail within a few days of
graft as a result of antibody and complement mediated
damage.15 16 Thus, immune privilege is easily overwhelmed in
the specific situation of transplantation into the cornea or at
the ocular surface, despite multiple mechanisms that act to
limit immune responsiveness.
We hypothesised that, should Fas ligand mediated
apoptosis of infiltrating leucocytes be an important mechan-
ism responsible for corneal privilege5 and corneal allograft
survival in particular,6 then Fas ligand might be down-
regulated in acute corneal graft rejection and that a brief
window might exist during which apoptosis did not occur.
We tested this hypothesis in a model of orthotopic corneal
transplantation in the rat.
METHODS
Corneal transplantation
Fischer 344 (F344; major histocompatibility complex (MHC)
haplotype RTlv1) and Wistar-Furth (WF; MHC haplotype
RTu) rats were bred within the institution. F344 rats were
recipients of corneal grafts from either F344 (isograft) or WF
(allograft) donors. Unilateral right 3 mm diameter penetrat-
ing orthotopic corneal transplantation was performed under
general anaesthesia between adult sex matched pairs as
previously described.17 Rejection appeared as increasing
corneal opacification in a previously thin, clear corneal graft
and was always associated with graft neovascularisation. The
day of rejection was defined as the day that iris margins were
no longer clearly visible through the grafted cornea. Median
corneal graft survival in the WF to F344 strain combination is
16–17 days18: indefinite graft survival was defined as survival
of a clear graft for at least 60 days.
Abbreviations: ACAID, anterior chamber associated immune
deviation; dUTP, deoxy-uridine triphosphate; FCS, fetal calf serum;
MHC, major histocompatibility complex; NSS, normal swine serum; PBS,
phosphate buffered saline; RT, room temperature; TUNEL, terminal
deoxynucleotidyl transferase mediated dUTP biotin nick end labelling
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Immunohistochemistry
Polyclonal rabbit anti-rat CD95L (Fas ligand) antibodies
(FAS-L (N-20) #sc-834, detecting amino acids mapping to
the amino terminus of rat CD95L; FAS-L (C-178) #sc-6237,
detecting amino acids mapping to the carboxy terminus of rat
CD95L) (Santa Cruz Biotechnologies Inc, Santa Cruz, CA,
USA) were used at 5 mg/ml. Heat inactivated normal rabbit
serum diluted to 5 mg/ml immunoglobulin was used as the
normal control. Grafted eyes were fixed 2–4 hours at 4 C˚ in
paraformaldehyde-lysine-periodate solution,19 soaked for
18 hours at 4 C˚ in 7% weight/volume (w/v) sucrose in
phosphate buffered saline (PBS; 150 mM NaCl, 6 mM
Na2HPO4, 4 mM KH2PO4, pH 7.2) and subsequently for
6 hours in 15% w/v sucrose in PBS before snap freezing in
liquid nitrogen. Sections cut at 8 mm on the cryostat were
transferred to chrome-alum subbed slides and blocked in
10% volume/volume (v/v) heat inactivated normal swine
serum (NSS; Trace Biosystems, Sydney, Australia) at room
temperature (RT). They were incubated with primary anti-
body for 18 hours at RT and washed three times with PBS
containing 0.2% w/v gelatin (Ajax, Auburn, Australia).
Following incubation with biotinylated affinity isolated sheep
anti-rabbit immunoglobulins (Silenus, Melbourne, Australia)
diluted 1/100 in PBS containing 1% v/v heat inactivated
normal rat serum, 1% heat inactivated NSS, and 1% heat
inactivated fetal calf serum (FCS; Trace Biosystems, Sydney,
Australia) for 30 minutes at RT, sections were washed three
times with PBS-gelatin and incubated with horseradish
peroxidase conjugated streptavidin (Dako Corporation,
Carpinteria, CA, USA) diluted 1/1000 in PBS for 30 minutes
at RT, and washed three times in PBS-gelatin. The reaction
product was developed for 5 minutes with a solution of 0.1 M
TRIS-HCl buffer, pH 7.6, containing 0.3% w/v sodium azide,
0.6 mg/ml 3,3’ diaminobenzidine tetrahydrochloride (Sigma
Chemical Company, St Louis, MO, USA), 10 mM imidazole,
and 0.07% v/v hydrogen peroxide (Ajax, Auburn, Australia).
Sections were counterstained with haematoxylin, dehydrated
through graded alcohols to xylene and mounted in Depex
(BDH, Poole, UK).
Immunohistochemistry using monoclonal antibodies on
paraformaldehyde-lysine-periodate fixed sections of grafted
eyes was performed as described elsewhere.16 Monoclonal
antibodies were undiluted culture supernatants from sta-
tionary phase murine hybridoma cultures obtained from the
ECACC (Porton Down, Salisbury, Wiltshire, UK) unless
otherwise specified. Isotype matched negative controls X63
(IgG1) and SAL5 (IgG2a) were the gift of Professor H Zola,
Adelaide, Australia; OX18, an anti-MHC class I antibody, was
the positive control. Specific antibodies included OX1, anti-
CD45; OX35, OX38, W3/25, all anti-CD4; OX8, anti-CD8;
NDS61, anti-IL-2R; OX42, anti-iC3b receptor (macrophage
and granulocyte); ED1, anti-macrophage, monocyte, and
some dendritic cells. Sections were counterstained with
haematoxylin to allow nuclear morphology to be assessed.
Staining was assessed at the light microscope using a
semiquantitative scoring system as follows: 2 = no
positively stained infiltrating cells; + = few positively stained
infiltrating cells; ++ = moderate number of positively
stained infiltrating cells; +++ = many positively stained
infiltrating cells. Sections from two to three isografts and two
to three allografts were examined at days 5, 7, 12, 14, 21, and
28 post-graft.
Terminal deoxynucleotidyl transferase mediated dUTP
biotin nick end labelling (TUNEL)
TUNEL was performed according to a modification of a
published method.20 Grafted rat eyes or lymph nodes from
normal rats were removed post mortem, fixed in 4% buffered
formalin for a minimum of 24 hours and paraffin embedded.
Sections of 5 mm were adhered to slides precoated with a 1/50
dilution of Histogrip (Zymed, San Francisco, CA, USA) in
acetone, deparaffinised, hydrated through graded alcohols to
distilled water, and permeabilised with 4 mg/ml proteinase K
(Merck, Darmstadt, Germany) for 10 minutes at RT. Nick
end labelling was accomplished by incubating sections with
0.11 units/ml terminal deoxynucleotidyl transferase in pH 6.6
buffer containing 5 mM cobalt chloride, 200 mM potassium
cacodylate, 25 mM TRIS-HCl, 250 mg/ml bovine serum
albumin, 0.375 nM biotinylated deoxy-uridine triphosphate
(dUTP), and 75 mM deoxy-adenosine triphosphate (all from
Boehringer-Mannheim, Mannheim, Germany) for 60 min-
utes at 37 C˚. The reaction was terminated by washing in
0.6 M sodium chloride/0.06 M sodium citrate buffer for
15 minutes at RT, in PBS for 1 minute at RT, and in PBS
containing 2% v/v FCS and 0.2% v/v Triton-X100 (Sigma, St
Louis, MO, USA) for 30 minutes at RT. Non-specific binding
sites were blocked with 10% heat inactivated NSS for
10 minutes at RT, and the sections were washed for
10 minutes with PBS-gelatin before endogenous peroxidase
was blocked with 0.09% v/v H2O2 in methanol for 20 minutes
at RT. Sections were washed in PBS-gelatin for 10 minutes at
RT, and then incubated with a 1/300 dilution of horseradish
peroxidase conjugated streptavidin (Dako Corporation,
Carpinteria, CA, USA) in PBS for 1 hour at RT. Sections
were washed three times with PBS-gelatin, and were then
developed, counterstained, and mounted as described above.
Negative control sections were stained identically, but with
omission of biotinylated dUTP from the nick end labelling
mixture.
Video image analysis of TUNEL sections
A whole sagittal section through the centre of each grafted
cornea was examined. Sections were scanned at 2006
magnification using a video image analysis system (Video-
Pro 32; Leading Edge Pty Ltd, Adelaide, Australia). Images
were captured using a Panasonic CCD video camera and
digitised with a PV 100 16 bit colour video digitiser card in an
Intel 80486 DX processor based personal computer. The
digitised image was displayed on a SVGA monitor in a
6406480 pixel variable window with 21 bit resolution.
Transmitted light intensity and stability of light output were
standardised as described elsewhere.21 Video image analysis
measurements were made of the total area stained blue (by
haematoxylin) and brown (by the TUNEL chromogen
product). The total number of haematoxylin stained cell
nuclei (representing nuclei of corneal cells and infiltrating
cells) in each field was determined using feature counting.
Staining with Hoechst dye 33258
Hoechst dye 33258 (bis-benzimide; Sigma, St Louis, MO,
USA) was used to visualise apoptotic nuclei.22 Rat thymus
was teased apart with forceps in HEPES RPMI 1640 medium
supplemented with 100 units/ml penicillin, 100 mg/ml strep-
tomycin, and 2 mM glutamine (all from ICN-Flow, Sydney,
Australia) and 10% v/v heat inactivated FCS. The cell
suspension was filtered through a sterile gauze, washed
twice in medium and adjusted to 46107 viable cells/ml. Equal
volumes of cell suspension were incubated for 20 hours at
37 C˚ with or without 1 mM dexamethasone (David Bull
Laboratories, Melbourne, Australia). The cells were washed
in medium, fixed for 10 minutes at RT in 2.6% v/v
formaldehyde, 2% w/v glucose, and 0.005 M NaN3 in PBS,
washed twice in distilled water, and adjusted to 56106 cells/
ml. A volume of 10 ml of cell suspension was smeared on a
glass slide, allowed to air dry and stained with 10 mg/ml
Hoechst dye 33258 in distilled water for 30 minutes at RT.
The slides were washed twice in distilled water, air dried and
mounted in 50% v/v glycerol in PBS. To prepare whole
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mounts, rat corneas were excised at the limbus, immersed in
the dye solution for 30 minutes at RT, washed twice by
immersion in distilled water, and mounted in 50%v/v glycerol
in PBS. Smears and whole mounts were examined under the
fluorescence microscope at an excitation wavelength of 360–
370 nm.
RESULTS
Fas ligand as detected by FAS-L (N20) was present on normal
rat corneal epithelium and endothelium (fig 1). Similar
expression was observed on rat corneal allografts harvested at
15 days post graft during acute rejection (fig 1). No down-
regulation of Fas ligand was apparent: expression may have
actually been upregulated. The same pattern of expression
was seen with FAS-L (C-178) (data not shown).
Apoptotic nuclei in sections of rat tissue were visualised by
TUNEL. Some positive staining of cells in the corneal
epithelium of normal rat corneas was observed and occa-
sional keratocytes and corneal endothelial cells were also
positive (fig 2A). Many cells infiltrating rat corneal isografts
(fig 2B) and the majority of cells infiltrating acutely rejecting
allografts (fig 2D) were TUNEL positive. Apoptotic mono-
nuclear cells were observed attached to the corneal endothe-
lium. Some keratocytes also appeared TUNEL positive. No
staining was observed in the controls in which biotinylated
dUTP was omitted (fig 2C). Rat lymph node showed very few
strongly TUNEL positive cells confined to germinal centres
(fig 2E, F), thereby confirming that the strong positive
staining observed in the corneal grafts was not non-specific
staining of all leucocytes.
In a kinetic study, grafts were stained for TUNEL at
postoperative day 0 (immediately post-graft), day 5 (when
infiltrating cells were first observed in the grafted tissue), day
10 (early allograft rejection), day 15 (acute allograft rejec-
tion), day 21 (late allograft rejection), and (in the case of
isografts only) more than 60 days (long surviving grafts). The
percentages of TUNEL positive nuclei in the stroma of corneal
allografts, time matched isografts, and normal control rat
corneas were quantified by video image analysis (table 1).
The striking increase in the percentage positivity observed
with increasing time after transplantation in rejecting
allografts primarily reflected the greater number of infiltrat-
ing mononuclear cells contributing to the total cell count at
these times.
To confirm the TUNEL results using another method of
detecting apoptotic nuclei, corneas were stained with Hoechst
dye 33258. As a positive control, apoptosis was induced in a
suspension of rat thymocytes by incubation with dexametha-
sone. After staining with Hoechst 33258, the preparation
showed many small bright fragmented nuclei with con-
densed chromatin, typical of apoptotic figures (fig 3A).
Comparison of normal rat corneas (fig 3B) and rejecting
corneal allografts (fig 3C) similarly stained with Hoechst
33258 and examined as whole mounts showed numerous
brightly staining nuclei with condensed chromatin in the
stroma of the latter only.
Figure 1 Immunoperoxidase staining.
(A) Normal rat corneal epithelium,
negative control: normal rabbit serum,
5 mg/ml total immunoglobulin; (B)
normal rat corneal endothelium and
posterior stroma, negative control:
normal rabbit serum, 5 mg/ml total
immunoglobulin; (C) normal rat corneal
epithelium, anti-Fas ligand (FAS-L
(N20)), 5 mg/ml specific antibody; (D)
normal rat corneal endothelium and
posterior stroma, anti-Fas ligand (FAS-L
(N20)), 5 mg/ml specific antibody; (E)
corneal allograft, day 15 post-graft,
negative control: normal rabbit serum,
5 mg/ml total immunoglobulin; (F)
corneal allograft, day 15 post-graft,
anti-Fas ligand (FAS-L (N20)), 5 mg/ml
specific antibody. A light haematoxylin
counterstain was applied to all sections;
the dark brown staining represents
diaminobenzidine reaction product.
634 Williams, Standfield, Smith, et al
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To characterise more closely the phenotype of the TUNEL
positive cells infiltrating isografts and allografts in this
model, immunohistochemistry for rat leucocytic markers
was performed on isografts and allografts at varying time
points after graft (table 2). No staining was observed with the
negative control antibodies in any section and the positive
Figure 2 TUNEL staining. (A) Normal rat cornea; (B) corneal isograft,
day 15 post-graft; (C) corneal allograft, day 15 post-graft: negative
control, dUTP omitted from nick end labelling mixture; (D) corneal
allograft, day 15 post-graft; (E) normal rat lymph node: negative control,
dUTP omitted from nick end labelling mixture; (F) normal rat lymph node.
A light haematoxylin counterstain was applied to all sections; the dark
brown staining represents the TUNEL reaction product.
Table 1 Percentage of TUNEL positive nuclei in grafted rat corneas at various times after
transplantation
Specimen No of eyes*
Mean (SD) % TUNEL +
nuclei in corneal stroma
Without dUTP With dUTP`
Normal corneas 5 1.7 (2.3) 29.3 (15.3)
Isograft day 0 3 1.5 (3.1) 35.3 (17.6)
Isograft day 5 3 1.7 (2.7) 50.1 (19.2)
Isograft day 10 3 0.3 (0.8) 33.9 (14.8)
Isograft day 14 3 1.5 (1.4) 47.9 (28.8)
Isograft day 21 3 0.4 (0.9) 65.0 (22.8)
Isograft day .60 4 0.9 (0.9) 42.5 (16.3)
Allograft day 0 3 2.1 (4.0) 29.2 (19.9)
Allograft day 5 3 2.4 (3.0) 57.8 (10.4)
Allograft day 10 3 0.8 (0.9) 75.3 (12.4)
Allograft day 15 3 8.4 (4.7) 93.6 ( 6.3)
Allograft day 21 3 0.8 (1.4) 78.3 (18.0)
*Only one eye of any rat was grafted for ethical reasons, therefore number of eyes represents number of rats.
Control for TUNEL reaction (biotinylated dUTP omitted from reaction).
`Test for TUNEL reaction (biotinylated dUTP included in reaction).
Figure 3 Hoechst dye 33258 staining. (A) Rat thymocytes incubated
20 hours at 37 C˚ with 1 mM dexamethasone; (B) whole mount of
normal rat cornea; (C) whole mount of rejecting corneal allograft.
Corneal grafts reject despite FasL expression 635
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control antibody showed appropriate staining in all sections.
In isografts, a few CD45 positive cells had moved into the
graft by the fifth postoperative day, clustered primarily in the
periphery around the graft sutures. These cells were
predominantly granulocytes, macrophages, and/or dendritic
cells as judged by positivity with OX42 and ED1. Cells bearing
T cell markers were extremely rare in isografts at all times
examined. No leucocytes were observed in the anterior
chamber of isografts at any time. In allografts, an early
infiltrate of granulocytes, macrophages, and/or dendritic cells
at the graft-host junction was observed. At day 5 post-graft,
there were more cells bearing the iC3b receptor in allografts
than in isografts. T cells were already present in allografts at
day 5 post-graft and increased in number in the central
cornea during rejection. The influx of CD4 positive cells
preceded the influx of CD8 positive cells by at least a week.
CD4 positive cells were also found in the anterior chamber
after 1 week, whereas CD8 positive cells were not noted until
day 21. Small numbers of neutrophils were identified by their
nuclear morphology in some allografts.
Dual immunoperoxidase and TUNEL staining on the same
sections was not performed because of the different proces-
sing required for the two protocols. However, all sections
were inspected at the light microscope to assess concordance
of staining. As pointed out above, some corneal epithelial
cells, and occasional keratocytes and corneal endothelial
cells, were TUNEL positive and therefore presumably
apoptotic. These cells were readily identifiable from their
location and morphology and were apparent in normal
corneas, isografts, and allografts. The cells infiltrating
isografts were predominantly myeloid lineage cells with very
sparse numbers of T cells, and were mostly TUNEL positive
irrespective of phenotype. These same cells were also TUNEL
positive in allografts but the majority of infiltrating cells,
especially in the central areas of the grafts, were TUNEL
positive T cells.
DISCUSSION
In normal rat cornea, Fas ligand was detected by immuno-
histochemistry on epithelial and endothelial cells. Both
mouse5 6 and human6 cornea have previously been shown
to express Fas ligand constitutively, and thus our finding was
not unexpected. However, the rejection rate of normal
murine corneal grafts has been reported to be of the order
of 45–47% across at common strain combinations.6 7 In
contrast, approximately 85–100% of corneal grafts from WF
donors to F344 recipients are rejected at a median of 16–
17 days postoperatively18 without the need for deliberate
prevascularisation of the recipient cornea. In the light of
these differences, we hypothesised that Fas ligand might be
significantly downregulated during acute corneal graft
rejection in the rat, thereby allowing infiltrating T cells to
survive and mediate rejection. However, in this model both
epithelial and endothelial cells remained strongly positive for
Fas ligand product as detected by two different antibodies
against the amino and carboxy termini, respectively, of the
molecule.
The expected result of expression of Fas ligand would be
induction of apoptosis in Fas bearing infiltrating leucocytes
(including CD4+ T cells, CD8+ T cells, neutrophils, and
macrophages) as has already been shown in transplanted
corneas in the mouse,6 and this was precisely what we
observed. The TUNEL method was used to visualise apoptotic
cells and was coupled with video image analysis for the
quantification of the number of apoptotic nuclei. Normal rat
corneas exhibited some positive TUNEL staining in epithe-
lium, as has been reported previously.23 Occasional kerato-
cytes and corneal endothelial cells were also TUNEL positive,
but there was no leucocytic infiltrate in normal corneas. In
contrast, isografts showed a slight cellular infiltrate of cells
bearing myeloid lineage markers that were mostly localised
to the area of the graft-host junction, whereas allografts
showed a more marked, central infiltrate of leucocytes that
were predominantly T cells. The identity and kinetics of
infiltration of leucocytes in rat corneal isografts and allografts
was essentially as has been described previously in our own
and other laboratories.18 24–26 Virtually all infiltrating leuco-
cytes in both isografts and allografts were apoptotic as judged
by positive TUNEL staining.
We examined the time of appearance of apoptotic cells in
rejecting orthotopic rat corneal grafts and in time matched
isografts. Metalloproteinases have been reported to release
human Fas ligand from the cell surface27; the cleaved soluble
Fas ligand is an inefficient trigger of apoptosis and instead
may competitively inhibit membrane bound Fas ligand
induced cell death.28 29 Furthermore, Fas ligand induced
killing of T cells requires T cell receptor stimulation.30 31 We
therefore suspected that there might be a brief time period
during which infiltrating cells in allografts were TUNEL
negative, perhaps through release of Fas ligand from the
surface of corneal cells, and that the small number of T cells
infiltrating isografts might not undergo apoptosis because
their T cell receptors would not have been ligated by foreign
antigen. However, cells infiltrating both isografts and
allografts appeared to undergo apoptosis as soon as they
interacted with corneal tissue, although the effect was more
pronounced in the allografts. An infiltrate was first observed
at the light microscope at about day 5 postoperatively and at
Table 2 Identity of cells infiltrating rat corneal isografts and allografts
Antibody specificity Specimen*
Cellular infiltrate at day post-graft
5 7 12 14 21 28
CD45 Isograft + + + ++ ++ +/2
Allograft ++ ++ ++ +++ +++ ++
CD4 Isograft 2 + + 2 +/2 +/2
Allograft +/2 + ++ ++ ++ +/2
CD8 Isograft 2 + 2 2 NT 2
Allograft +/2 +/2 +/2 +/2 ++ +
IL2R Isograft 2 2 +/2 2 2 2
Allograft 2 2 +/2 + ++ +
iC3bR Isograft + + + + NT 2
Allograft +++ + + ++ ++ ++
ED1 Isograft +++ + + + + 2
Allograft +++ + + ++ ++ ++
*2–3 eyes were examined per time point.
2 = no positively stained infiltrating cells; + = few positively stained infiltrating cells; ++= moderate number of positively stained infiltrating cells; +++ = many
positively stained infiltrating cells.
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this time point, the infiltrating cells were already TUNEL
positive. We did not observe a window in which infiltrating
cells were TUNEL negative: the increasing percentage of
TUNEL positive nuclei observed with increasing time post-
graft reflected a steady increase in the number of infiltrating
leucocytes present in the corneal tissue. Modulators of
apoptosis, such as Bcl-2 and various growth factors, are
expressed by human corneal cells, in tissue sections and/or in
culture.32–34 Expression of such modulators may be altered
during corneal graft rejection, but not to the extent that
apoptosis is blocked.
TUNEL has been used previously to study apoptosis within
the cornea,35 36 and we consider our staining technique to be
reliable. Firstly, the negative controls (in which biotinylated
dUTP was omitted) consistently showed minimal positive
staining (table 1). Secondly, normal cornea showed the
expected pattern of TUNEL positivity (primarily in basal
epithelium), whereas normal rat lymph node was negative.
Thirdly, apoptotic nuclei within allografts (but not normal
corneas) were directly visualised by staining of corneal whole
mounts with the nuclear dye Hoechst 33258, an independent
test for condensed chromatin and apoptotic-like nuclear
figures. Attempts to confirm the TUNEL staining37 38 by
extracting DNA from rejecting corneal grafts and running the
extracts on agarose gels20 produced inconsistent DNA
laddering, because the small size of the grafts limited the
amount of DNA available for extraction (data not shown).
Finally, induction of apoptosis in infiltrating Fas positive cells
was entirely consistent with the observation that the cornea
continued to express Fas ligand during the rejection process.
Our data do not allow us to draw a causal link between Fas
ligand expression and induction of apoptosis in cells
infiltrating corneal grafts in the rat, but elegant experi-
ments6 7 in which the incidence of corneal allograft rejection
was strongly enhanced when mutant Fas ligand negative
(gld) were used as donors provide such evidence for the
mouse and, by extension, for other species.
How, then, do corneal grafts undergo rejection? Corneal
graft rejection appears histologically to be an inflammatory
process with characteristics typical of a delayed type
hypersensitivity response: the infiltrate is mixed, but is
composed predominantly of T cells.39–41 In the non-inflam-
matory programmed cell death that occurs as part of normal
development, apoptotic nuclei are quickly cleared by phago-
cytosis.42 TUNEL positive cells may accumulate in rejecting
corneal grafts because there are insufficient phagocytic cells
present in the grafts to clear the substantial number of dead
and dying T cells. Although apoptosis is a rapid process, it
may be that infiltrating T cells can kill their targets more
quickly, so that ‘‘murder’’ precedes ‘‘suicide.’’43 Alternatively,
Sonoda and colleagues have shown that CD1d positive NKT
cells can induce allospecific regulatory T cells that may
promote corneal graft survival.44 Should these cells be
induced to undergo apoptosis early in the alloresponse, then
perhaps a crucial control mechanism may be abrogated.
It has been suggested that the ‘‘immunological privilege’’
enjoyed by the eye and the testis, two organs that express Fas
ligand constitutively, might be adapted to prevent the
rejection of other grafts by using Fas ligand as a natural
immunosuppressant.45 46 Fas ligand transfected myoblasts
syngeneic with murine recipients have been reported to
prevent rejection of co-transplanted islet allografts.47
However, Allison and his colleagues48 have reported that
expression of Fas ligand on fetal pancreatic islets taken from
mice transgenic for CD95L failed to protect those grafts from
rejection and, furthermore, the transgenic donors developed
a granulocytic infiltration of islet tissue. Our data suggest
acute corneal graft rejection occurs in the presence of
expressed Fas ligand even in otherwise normal recipient
eyes. In eyes that have been inflamed or where the cornea is
vascularised,9 10 there is overwhelming evidence in a variety
of species, including humans, to support the contention that
rejection is the expected outcome for corneal grafts. Immune
privilege in the eye is plainly relative and can be overcome,
but the mechanism by which rejection occurs, given that so
many of the cells presumed to be involved are dead, remains
obscure.
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